GlassScriptPhysician profile
Jason B Harn
NPI 1285837476
$13,510.04
in general payments reported to CMS, 2019-2025
28 companies · $6,740 in 2025
The $6,740 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $446 · 2020: $206 · 2021: $594 · 2022: $428 · 2023: $264 · 2024: $4,831 · 2025: $6,740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,200.00 |
| Food and Beverage | $634.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $11,217.54 | 2024-2025 | Bovine Collagen |
| Abbvie INC. | $528.09 | 2019-2023 | |
| Celularity INC. | $300.00 | 2019 | |
| Sage Therapeutics, LLC | $148.28 | 2022-2025 | Zurzuvae |
| Organon LLC | $127.98 | 2021-2025 | Jada System, Nexplanon |
| Exeltis, USA INC. | $126.05 | 2019-2023 | Slynd |
| Daiichi Sankyo INC. | $117.05 | 2022-2024 | Injectafer |
| Gynesonics, INC. | $111.05 | 2021 | |
| Roche Diagnostics Corporation | $103.99 | 2021 | |
| Mayne Pharma Commercial LLC | $93.49 | 2022-2024 | |
| Avion Pharmaceuticals | $75.77 | 2019-2022 | |
| Minerva Surgical, INC | $74.59 | 2022-2023 | |
| Ethicon US, LLC | $74.42 | 2021-2024 | Surgicel Nu-Knit, Vistaseal, Dermabond Prineo |
| Millicent US INC | $69.67 | 2024-2025 | Femlyv, Femring, Intrarosa |
| Hologic Sales and Service, LLC | $48.15 | 2020-2024 | Acessa Provu System |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $41.48 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.60 | 2019-2020 | |
| Astellas Pharma US INC | $31.05 | 2023 | Veozah |
| Therapeuticsmd, INC. | $26.24 | 2019-2022 | |
| Allergan, INC. | $25.40 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $23.57 | 2019-2021 | |
| Coopersurgical, INC. | $19.36 | 2023 | Paragard T 380a |
| Pacira Pharmaceuticals Incorporated | $19.04 | 2019 | |
| Dysis Medical, INC. | $16.66 | 2022 | |
| Bausch Health US, LLC | $15.89 | 2021 | |
| Aspira Women'S Health INC | $15.11 | 2019 | |
| Amag Pharmaceuticals, INC. | $14.78 | 2021 | |
| Medicem INC. | $11.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Harn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.